GlassScriptPhysician profile
S L Lampkin
NPI 1275583163
$1,553.26
in general payments reported to CMS, 2019-2025
19 companies · $395 in 2025
The $395 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $277 · 2020: $144 · 2021: $153 · 2022: $194 · 2023: $77.94 · 2024: $313 · 2025: $395.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $786.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $786.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $384.04 | 2019-2022 | |
| Pfizer INC. | $172.11 | 2019-2024 | |
| Vanda Pharmaceuticals INC. | $160.40 | 2021-2023 | Hetlioz |
| Astrazeneca Pharmaceuticals LP | $138.95 | 2024-2025 | Farxiga |
| Kowa Pharmaceuticals America, INC. | $120.77 | 2025 | Zoryve |
| Exact Sciences Corporation | $102.75 | 2023-2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $77.81 | 2019-2025 | Veozah |
| Merck Sharp & Dohme LLC | $72.73 | 2023-2025 | Gardasil 9, Capvaxive, Vaxneuvance |
| Sanofi-Aventis U.S. LLC | $54.06 | 2024 | |
| Seqirus USA INC | $41.96 | 2021-2025 | Flucelvax, Fluad |
| Ucb, INC. | $40.95 | 2024 | Nayzilam |
| Novo Nordisk INC | $28.04 | 2024 | Rybelsus, Ozempic |
| Beta Bionics, INC. | $24.89 | 2024 | Ilet Bionic Pancreas |
| Bayer Healthcare Pharmaceuticals INC. | $24.88 | 2024 | |
| Abbvie INC. | $24.41 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $22.93 | 2025 | Minimed 780g |
| Hologic Sales and Service, LLC | $22.91 | 2025 | Aptima |
| Janssen Pharmaceuticals, INC | $22.57 | 2023 | Xarelto |
| Avanir Pharmaceuticals, INC. | $16.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw S Lampkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.